UnitedHealth Group Included (NYSE:UNH) is included among the many 12 Finest DOW Shares to Purchase in 2026.
On January 5, Barclays analyst Andrew Mok raised his value goal on UnitedHealth Group Included (NYSE:UNH) to $391 from $386 and stored an Chubby ranking. The agency expects managed care shares to profit in 2026 as margins get well and investor consideration shifts away from synthetic intelligence names towards shares which were left behind.
UnitedHealth’s share value tells a harder story within the close to time period. The inventory is down almost 35% in 2025. Increased-than-expected visits to medical doctors and surgeons weighed on outcomes, driving up medical prices. In Could, the corporate suspended its full-year revenue forecast after posting its first quarterly earnings miss in additional than a decade.
Administration pointed to rising utilization. Extra physician visits and surgical procedures meant larger insurance coverage payouts, and the corporate mentioned it couldn’t reliably estimate how a lot these prices may climb. Pulling steering added uncertainty, and buyers reacted rapidly. That call turned a transparent warning signal for the market and helped gas the inventory’s sharp decline this 12 months. UnitedHealth’s adjusted EPS for 2025 is anticipated to be no less than $16.25. Any outlook for 2026 that is available in solely modestly above that degree might immediate buyers to remain cautious.
UnitedHealth Group Included (NYSE:UNH) operates throughout medical insurance and well being companies. Its companies embody Optum Well being, Optum Perception, Optum Rx, and UnitedHealthcare, which serves employer, particular person, Medicare, retirement, and government-sponsored plans.
Whereas we acknowledge the potential of UNH as an funding, we consider sure AI shares provide higher upside potential and carry much less draw back threat. If you happen to’re on the lookout for a particularly undervalued AI inventory that additionally stands to profit considerably from Trump-era tariffs and the onshoring development, see our free report on the finest short-term AI inventory.
READ NEXT: 12 Finest Revenue Shares to Purchase Now and 20 Finest Performing Dividend Shares in 2025
Disclosure: None.
